Jay T. Rubinstein, MD, PhD, highlighted promising CHORD trial data showing that DB-OTO gene therapy has led to hearing improvements in treated participants.
Jay Rubinstein, MD, PhD
Advertisement
Articles by Jay Rubinstein, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: What's new in COVID-19, RSV, and flu guidance?
2
FDA approves leniolisib for children aged 4 to 11 with APDS
3
A teenaged girl with flat-topped papules
4
From index of suspicion to managing survivorship: A primary care toolkit for childhood cancer
5